Angiology

Vascular Patches Market Worth 525.8 Million USD by 2023

Retrieved on: 
Tuesday, June 12, 2018
Medicine, Vascular surgery, Angiology, Circulatory system, Aortic aneurysm, Aneurysm, Vascular bypass, Abdominal aortic aneurysm, Endarterectomy

According to a new market research report "Vascular Patches Market by Material (Biologic, Synthetic), Application (Carotid Endarterectomy, Open Repair of Abdominal Aortic Aneurysms, Vascular Bypass Surgery), Patient Care Setting (Hospitals, Ambulatory Surgical Centers) - Global Forecast to 2023", published by MarketsandMarkets, the market is expected to reach USD 525.8 Million by 2023 from USD 349.6 Million in 2018, at a CAGR of 8.5%.

Key Points: 
  • According to a new market research report "Vascular Patches Market by Material (Biologic, Synthetic), Application (Carotid Endarterectomy, Open Repair of Abdominal Aortic Aneurysms, Vascular Bypass Surgery), Patient Care Setting (Hospitals, Ambulatory Surgical Centers) - Global Forecast to 2023", published by MarketsandMarkets, the market is expected to reach USD 525.8 Million by 2023 from USD 349.6 Million in 2018, at a CAGR of 8.5%.
  • Growth in the Vascular Patches Market is mainly driven by the rapidly growing geriatric population and the subsequent increase in the prevalence of vascular diseases, the increasing number of vascular surgeries performed, and the increasing adoption of biological patches.
  • Based on material, the Vascular Patches Market is segmented into biologic vascular patches and synthetic vascular patches.
  • Of all these product segments, biologic vascular patches accounted for the largest share of the market in 2017.

Cook Medical faces $1.2 Million Verdict, Matthews & Associates Reports

Retrieved on: 
Wednesday, May 30, 2018
Medicine, Angiology, Clinical medicine, Inferior vena cava filter, Interventional radiology, Inferior vena cava, IVC, Venae cavae, Port, JONAH, Frederick Cook

HOUSTON, May 29, 2018 /PRNewswire/ --Cook Medical must pay $1.2 million to compensate a man who was implanted with a Cook Celect IVC filter, said a Texas jury Thursday.

Key Points: 
  • HOUSTON, May 29, 2018 /PRNewswire/ --Cook Medical must pay $1.2 million to compensate a man who was implanted with a Cook Celect IVC filter, said a Texas jury Thursday.
  • Following a three-week trial, the jury of 12 ruled Cook must pay for injuries following a Celect filter's implantation in Jeff Pavlock on March 3, 2015.
  • A 35-year-old Houston-area firefighter, Mr. Pavlock sued Cook after its Celect inferior vena cava filter required open laparotomy surgery to remove.
  • Cook's attorneys had also refuted trial evidence of doctors reporting only 1-5% of actual adverse events related to medical devices.

World Heart Federation: Tobacco is Responsible For More Than One in Ten Deaths Caused by Cardiovascular Disease

Retrieved on: 
Tuesday, May 29, 2018
RTT, Circulatory system, Angiology, Coronary artery disease, World Heart Federation, WHF, Peripheral artery disease, Stroke, Cardiovascular disease

Tobacco is associated with around 7 million deaths worldwide every year, directly related to the consumption of and indirect exposure to smoke.

Key Points: 
  • Tobacco is associated with around 7 million deaths worldwide every year, directly related to the consumption of and indirect exposure to smoke.
  • It increases blood rate and blood pressure and replaces oxygen, making it an important risk factor in the development of coronary disease, stroke and peripheral vascular disease.
  • Given that CVDs constitute the number one cause of death in the world, the World Heart Federation (WHF) applauds this initiative by the World Health Organization (WHO).
  • On 29 September, WHF will be celebrating World Heart Day with the objective of raising awareness about the importance of good cardiovascular health.

World Heart Federation: Tobacco is Responsible For More Than One in Ten Deaths Caused by Cardiovascular Disease

Retrieved on: 
Tuesday, May 29, 2018
RTT, Circulatory system, Angiology, Coronary artery disease, World Heart Federation, WHF, Peripheral artery disease, Stroke, Cardiovascular disease

Tobacco is associated with around 7 million deaths worldwide every year, directly related to the consumption of and indirect exposure to smoke.

Key Points: 
  • Tobacco is associated with around 7 million deaths worldwide every year, directly related to the consumption of and indirect exposure to smoke.
  • It increases blood rate and blood pressure and replaces oxygen, making it an important risk factor in the development of coronary disease, stroke and peripheral vascular disease.
  • Given that CVDs constitute the number one cause of death in the world, the World Heart Federation (WHF) applauds this initiative by the World Health Organization (WHO).
  • On 29 September, WHF will be celebrating World Heart Day with the objective of raising awareness about the importance of good cardiovascular health.

World Heart Federation: Tobacco is Responsible For More Than One in Ten Deaths Caused by Cardiovascular Disease

Retrieved on: 
Tuesday, May 29, 2018
RTT, Circulatory system, Angiology, Coronary artery disease, World Heart Federation, WHF, Peripheral artery disease, Stroke, Cardiovascular disease

Tobacco is associated with around 7 million deaths worldwide every year, directly related to the consumption of and indirect exposure to smoke.

Key Points: 
  • Tobacco is associated with around 7 million deaths worldwide every year, directly related to the consumption of and indirect exposure to smoke.
  • It increases blood rate and blood pressure and replaces oxygen, making it an important risk factor in the development of coronary disease, stroke and peripheral vascular disease.
  • Given that CVDs constitute the number one cause of death in the world, the World Heart Federation (WHF) applauds this initiative by the World Health Organization (WHO).
  • On 29 September, WHF will be celebrating World Heart Day with the objective of raising awareness about the importance of good cardiovascular health.

Tasigna Lawsuit News: Recent Studies Suggest Leukemia Drug May Increase Risk for Arteriosclerosis, Peripheral Artery Disease and Related Vascular Conditions, Bernstein Liebhard LLP Reports

Retrieved on: 
Thursday, May 17, 2018
Angiology, RTT, Circulatory system, Medicine, Interventional radiology, Angioplasty, Peripheral artery disease, Arteriosclerosis, Leukemia, Artery disease

All three required angioplasty and none had a prior history of peripheral artery disease before they began taking Tasigna.

Key Points: 
  • All three required angioplasty and none had a prior history of peripheral artery disease before they began taking Tasigna.
  • In 2013, researchers writing in the journal Leukemia reported that patients taking Tasigna were more likely to experience peripheral artery disease compared to those taking another CML drug called Gleevac.
  • "Our Firm has heard from numerous patients who were diagnosed with arteriosclerosis, peripheral artery disease, or related conditions after they began taking Tasigna to treat CML.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street,New York, New York10016, 800-511-5092.

Amgen Receives European Commission Approval For Repatha® (Evolocumab) To Prevent Heart Attack And Stroke In Adults With Established Cardiovascular Disease

Retrieved on: 
Wednesday, May 16, 2018
RTT, Circulatory system, Medicine, Angiology, Coronary artery disease, Angina, Unstable angina, Atherosclerosis, Myocardial infarction, Cardiovascular disease, Clinical endpoint, Stroke

"With its proven ability to prevent heart attacks and strokes, Repatha offers hope for one of the greatest health challenges we face today.

Key Points: 
  • "With its proven ability to prevent heart attacks and strokes, Repatha offers hope for one of the greatest health challenges we face today.
  • "With far too many patients at risk of recurrent cardiovascular events, we are pleased that the European Commission has approved Repatha to prevent heart attacks and strokes in adults with established atherosclerotic cardiovascular disease.
  • The hard MACE composite endpoint was the time to cardiovascular death, myocardial infarction or stroke (key secondary endpoint).
  • The extended MACE composite endpoint was the time to cardiovascular death, myocardial infarction, stroke, or hospitalization for unstable angina or coronary revascularization (primary endpoint).

Chronic Heart Failure Pricing, Reimbursement, and Access Report 2018: Positive ICER Findings Likely to Increase Payer Acceptance of Entresto

Retrieved on: 
Friday, May 11, 2018
Medicine, Anatomy, Angiology, Endocrinology, Hypertension, Peptide hormones, Circulatory system, ACE inhibitors, Angiotensin, Renin, Heart failure, Antihypertensive drug

The "Chronic Heart Failure Pricing, Reimbursement, and Access" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Chronic Heart Failure Pricing, Reimbursement, and Access" report has been added to ResearchAndMarkets.com's offering.
  • Payers were originally extremely worried about the potential cost burden of Entresto, however, the level of concern surrounding the drug is currently moderate as physician uptake has been lower than expected.
  • Payers suggest that it will take some time for routine prescribing habits to change to incorporate Entresto, as physicians have been treating chronic heart failure patients with cheap angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for many years.
  • In addition to patient population and line of therapy restrictions, the majority of the markets surveyed b.

Eric Adam Heller, M.D., M.S., FACC, FSCAI, FSVM is recognized by Continental Who's Who

Retrieved on: 
Wednesday, April 25, 2018
Angiology, Circulatory system, Cardiology, Peripheral artery disease, Vein

Florida Premiere Cardiology is notorious for their superior approach when addressing the comprehensive medical needs of their clients.

Key Points: 
  • Florida Premiere Cardiology is notorious for their superior approach when addressing the comprehensive medical needs of their clients.
  • Devoted to providing their clients with quality healthcare services utilizing the latest advancements in medical technology, the facility ensures their clients' needs are met.
  • Offering an extensive range of services, the cardiology center specializes in cardiac procedures, cardiac evaluations, venous disease, and peripheral arterial disease.
  • With over seventeen years of experience in the field of Medicine under his belt, Dr. Eric Adam Heller has become a trusted name in the medical industry.

The Marfan Foundation & Backpack Health Partner to Offer Unique Tech Platform to Help People Living with Marfan Syndrome and Related Disorders

Retrieved on: 
Tuesday, April 24, 2018
Anatomy, Medicine, Angiology, Vascular diseases, RTT, Collagen disease, Marfan syndrome, Syndromes affecting the heart, Loeys–Dietz syndrome, Aortic aneurysm, Thoracic aortic aneurysm, MASS syndrome

The first-ever Marfan Syndrome and Related Disorders International Patient Registry is scheduled to launch in May 2018.

Key Points: 
  • The first-ever Marfan Syndrome and Related Disorders International Patient Registry is scheduled to launch in May 2018.
  • There are several disorders related to Marfan syndrome including Loeys-Dietz syndrome, Ehlers-Danlos syndrome, familial thoracic aortic aneurysm and dissection, MASS phenotype, ectopia lentis syndrome, Beals syndrome, bicuspid aortic valve, Stickler syndrome and Shprintzen-Goldberg syndrome.
  • The Marfan Foundation, with headquarters in Port Washington, NY, creates a brighter future for everyone affected by Marfan syndrome and related conditions.
  • Backpack Health provides a platform for organizations to engage patients, collect up-to-date data and build communities around the globe.